Sun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...

US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...

Sibal, a pharma industry veteran, is expected to join drug company Lupin later this month.

Sun Pharmaceutical Industries today said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals.

FTC has passed its final order settling charges that Sun Pharma's $4 billion deal to acquire Ranbaxy Laboratories could result in unfair bu...

Most executives from Ranbaxy's earlier team have already left the company in past one year.

How Sun Pharma integrates its business will be keenly followed, says Kohli. Merged entity will take some time to derive synergistic benefit...

Sun Pharma and Ranbaxy Labs, the rival it is in the process of acquiring, have set up an integration committee headed by Ranjan Chakravarti

After hearing the arguments from the counsels of the petitioners, Ranbaxy, Sun Pharma and SEBI, Justice G Chandraiah said he will pronounce...

The court had earlier issued interim orders to maintain status quo with regard to the merger.

Sun Pharma said it will take "appropriate action" in the wake of AP High Court suspending the co's $4 bn deal with Ranbaxy.

Sun Pharma will make an open offer worth Rs 18.4 crore to acquire a little over 28 per cent stake in Zenotech Laboratories Ltd.

Sun Pharma denied insider trading charges against Silverstreet Developers- its wholly owned arm - in the $4 bn acquisition deal of Ranbaxy ...

Analysts are betting around 20% return from the stock in the medium term. They say the stock could double investor wealth in two years.

Sebi would be closely looking at the Sun Pharma-Ranbaxy deal to ensure compliance with stringent norms that are in place for listed entitie...

Sun Pharma may not have to face surprises emanating from Ranbaxy. There is every likelihood that brand Ranbaxy will see a sunset clause whe...

Sun Pharmaceutical Industries said that it will buy generic drug maker Ranbaxy Laboratories, has hit regulatory snags in its key US market ...